President Donald Trump has been successful in convincing many of the world’s top drugmakers to commit to manufacturing more ...

It took several attempts and much debate, but on Friday, the Centers for Disease Control and Prevention's (CDC’s) newly ...

Interestingly, despite the autumn’s upward trend, November’s haul is the first in 2025 that doesn’t outweigh the ...

Uncertainty reigned early this year with the inauguration of President Donald Trump and his threats to impose tariffs and ...

With FDA approval to treat marginal zone lymphoma (MZL), Bristol Myers Squibb’s Breyanzi has become the first CAR-T therapy ...

Avalere Health has hired Sarah Hall as president of U.S. marketing, tapping the direct-to-consumer expert to lead its team ...

Halozyme is seeing some progress in its global effort to defend intellectual property against alleged infringement by Merck & ...

The FDA is investigating a safety signal from Takeda’s rare disease med Adzynma. Otsuka won a first-in-class FDA approval to ...

The Centers for Disease Control and Prevention's (CDC’s) newly reworked Advisory Committee on Immunization Practices (ACIP) ...

A trio of drugmakers are treading the boards to raise awareness of global antimicrobial resistance (AMR). | A trio of ...

The latest untitled letter from the FDA’s Office of Prescription Drug Promotion zeroes in on a patient testimonial video about Daiichi Sankyo’s tenosynovial giant cell tumor (TGCT) treatment, Turalio.

One day after the FDA’s new director of the Center for Drug Evaluation and Research (CDER), Richard Pazdur, M.D., informed ...